Literature DB >> 9162194

Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: a combined cytogenetic and comparative genomic hybridization study.

J Szymanska1, N Mandahl, F Mertens, M Tarkkanen, E Karaharju, S Knuutila.   

Abstract

Seven parosteal osteosarcoma (POS) samples, six of which were cytogenetically characterized, were studied by using comparative genomic hybridization (CGH). All samples showed DNA sequence copy number changes (mean, six aberrations/tumor; range, 1-13); gains were more frequent than losses. Gain of 12q13-15 sequences was found in every tumor and correlated with the presence of ring chromosomes. High-level amplification, which was detected in four tumors, was seen only in chromosome 12, with 12q13-14 as the minimal common region. By using chromosome painting, one of the rings of one case was shown to be composed entirely of chromosome 12 material. Together with previous data, our findings show that gain of 12q13-15 sequences is a characteristic feature of POS and that these sequences are contained within the ring chromosomes.

Entities:  

Mesh:

Year:  1996        PMID: 9162194     DOI: 10.1002/(SICI)1098-2264(199605)16:1<31::AID-GCC4>3.0.CO;2-4

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  13 in total

1.  Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker.

Authors:  M L Larramendy; M Tarkkanen; C Blomqvist; M Virolainen; T Wiklund; S Asko-Seljavaara; I Elomaa; S Knuutila
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Extragnathic fibromyxoma of bone versus inflammatory myofibroblastic tumor.

Authors:  M T Flores-Corral; C Ballestin; M A Martínez-Gonzalez; F J Martínez-Tello
Journal:  Skeletal Radiol       Date:  1998-08       Impact factor: 2.199

Review 3.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Authors:  S Knuutila; A M Björkqvist; K Autio; M Tarkkanen; M Wolf; O Monni; J Szymanska; M L Larramendy; J Tapper; H Pere; W El-Rifai; S Hemmer; V M Wasenius; V Vidgren; Y Zhu
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.

Authors:  Abberly Lott Limbach; Mark W Lingen; James McElherne; Heather Mashek; Carrie Fitzpatrick; Elizabeth Hyjek; Reza Mostofi; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2020-02-05

5.  Chromosome 12 long arm rearrangement covering MDM2 and RASAL1 is associated with aggressive craniofacial juvenile ossifying fibroma and extracranial psammomatoid fibro-osseous lesions.

Authors:  Flore Tabareau-Delalande; Christine Collin; Anne Gomez-Brouchet; Corinne Bouvier; Anne-Valérie Decouvelaere; Anne de Muret; Jean-Christophe Pagès; Gonzague de Pinieux
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

Review 6.  Translational biology of osteosarcoma.

Authors:  Maya Kansara; Michele W Teng; Mark J Smyth; David M Thomas
Journal:  Nat Rev Cancer       Date:  2014-10-16       Impact factor: 60.716

7.  A comparison of intramedullary and juxtacortical low-grade osteogenic sarcoma.

Authors:  Joseph H Schwab; Cristina R Antonescu; Edward A Athanasian; Patrick J Boland; John H Healey; Carol D Morris
Journal:  Clin Orthop Relat Res       Date:  2008-04-19       Impact factor: 4.176

8.  CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.

Authors:  G P Nielsen; K L Burns; A E Rosenberg; D N Louis
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

9.  The genetics of osteosarcoma.

Authors:  Jeff W Martin; Jeremy A Squire; Maria Zielenska
Journal:  Sarcoma       Date:  2012-05-20

10.  Expression of alternatively spliced isoforms of human Sp7 in osteoblast-like cells.

Authors:  Maria-athina Milona; Julie E Gough; Alasdair J Edgar
Journal:  BMC Genomics       Date:  2003-11-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.